FounderRecord

Didier Toubia

Co-Founder · CEO · Kfar Saba

French-Israeli food technology and life sciences entrepreneur. Co-founder and CEO of Aleph Farms, which received the world's first regulatory approval for cultivated beef in 2024. Previously co-founded IceCure Medical (IPO 2011) and led NLT Spine to acquisition by SeaSpine for up to $52.5M.

Based in Kfar Saba, IsraelLast reviewed October 2026
Didier Toubia
Photo: TWIN Global
Compiled from public sources. Didier Toubia has not yet contributed to this record.
Claim your record

Overview

Didier Toubia is a French-Israeli entrepreneur and the co-founder and CEO of Aleph Farms, a cellular agriculture company based in Rehovot, Israel, that grows beef steaks directly from animal cells.[1] In January 2024, Aleph Farms received the world's first regulatory approval for cultivated beef from Israel's Ministry of Health.[2] The company has raised approximately $148 million across four funding rounds.[6]

Before entering food technology, Toubia built a two-decade career across medical devices and life sciences in Israel. He co-founded IceCure Medical, a cryoablation company that completed an IPO on the Tel Aviv Stock Exchange in 2011,[16] and served as president and CEO of NLT Spine, which was acquired by SeaSpine Holdings for up to $52.5 million in 2016.[15] Toubia is a co-inventor of over 40 patent families spanning medical devices and cellular agriculture.[1]

Early life and education

Toubia grew up in Paris, France, where he has said his first job was in a meat processing facility.[6] He studied food engineering and biology at AgroSup Dijon (Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement), one of France's leading agronomy institutions, completing a Master of Engineering degree with a focus on food technologies for the developing world.[18] His thesis was conducted at the Technion – Israel Institute of Technology, establishing an early connection to the Israeli research ecosystem.[1]

Toubia subsequently earned a Specialized Master's degree in Financial Audit and Consulting from ESCP Business School in Paris (1995–1996).[8] In 2003–2004, he completed a joint International Executive MBA from the Kellogg School of Management at Northwestern University and the Recanati Graduate School of Business Administration at Tel Aviv University, with a focus on high-tech management.[1]

Career

IFC (International Finance Corporation) / World Bank (c. 1995–1997)

Toubia began his career at the International Finance Corporation, a branch of the World Bank, based in Côte d'Ivoire (Ivory Coast) in West Africa. The role focused on malnutrition and food security in developing nations.[18] Toubia has described this experience as formative, saying it shaped his understanding that hunger is a systemic problem rooted in how food systems are designed rather than a matter of insufficient production.[18]

Maya Software Technologies

After relocating to Israel, Toubia co-founded Maya Software Technologies, an early-stage technology venture in which he served as co-founder and COO.[19] Exact dates of operation are not publicly documented. The company represented Toubia's first entrepreneurial venture in Israel's technology sector, predating his transition into medical devices.[19]

SurgiVision Ltd. (2000–2005)

Toubia co-founded SurgiVision Ltd. around 2000, an Israeli medical device company developing electro-optical systems for neurosurgery and ear, nose, and throat (ENT) procedures. He served as co-founder and VP of business development.[19] The company raised over $7 million during his tenure.[19]

Cukierman & Co. Investment House

Between his medical device ventures, Toubia served as a partner in the life sciences practice at Cukierman & Co. Investment House, an Israeli investment banking firm.[10] The role provided Toubia with experience in life sciences investment and deal-making in the Israeli market. Exact dates are not publicly documented.[10]

IceCure Medical (2006–2011)

Toubia co-founded IceCure Medical in 2006, a company developing cryoablation technology for the minimally invasive destruction of tumors.[28] As co-founder and CEO, he led the company through its early development and to an initial public offering on the Tel Aviv Stock Exchange on February 2, 2011, raising more than $10 million.[16] IceCure Medical later dual-listed on the Nasdaq (ticker: ICCM) in August 2021, after Toubia's departure.[28] The company's ProSense system has been used for cryoablation of breast, kidney, and lung tumors, with distribution agreements in Japan and Singapore.[25]

Luneau Technology

Following his departure from IceCure Medical, Toubia served as a consultant for special projects at Luneau Technology, a French ophthalmic equipment company. In this role, he led the merger of two U.S. subsidiaries and the turnaround of an $18 million business unit.[19] Exact dates of the engagement are not publicly documented.

NLT Spine (c. 2009–2016)

Toubia joined NLT Spine, an Israeli spinal implant company founded in 2006 by Dr. Tzony Siegal, as president and CEO.[10] Under his leadership, the company grew from one employee to over 30 and developed expandable interbody fusion technologies for minimally invasive spine surgery.[19] In August 2016, NLT Spine was acquired by SeaSpine Holdings Corporation (NASDAQ: SPNE) in a deal valued at up to $52.5 million, comprising an upfront payment, contingent sales-based payments, stock consideration, and milestone payments.[15][13][15]

I think it's a misperception to think that just assembling existing technologies that have been transferred from the biomedical industry and scaling up production will be enough to reduce the cost to a level that will make cultivated meat competitive on price.McKinsey & Company interview

Aleph Farms (2017–present)

In 2016, Toubia was approached by The Kitchen FoodTech Hub, a food technology incubator operated by the Strauss Group, which had been collaborating with Professor Shulamit Levenberg of the Technion on applying tissue engineering technology — originally developed for regenerative medicine — to food production.[18] Toubia recognized that the cellular biology principles he had worked with in medical devices could be applied to growing structured beef cuts without animal slaughter. He co-founded Aleph Farms in 2017 together with Levenberg, with Dr. Neta Lavon joining as chief technology officer.[15]

The company raised a $2 million seed round from The Kitchen FoodTech Hub and New Crop Capital in 2017, followed by a $12 million Series A in May 2019 led by VisVires New Protein with participation from Cargill.[15][6] In December 2018, Aleph Farms unveiled the world's first cultivated thin-cut beef steak.[15] In July 2021, the company closed a $105 million Series B round led by L Catterton and DisruptAD (the venture platform of Abu Dhabi's ADQ), with participation from investors including Leonardo DiCaprio.[16][17]

In January 2024, Aleph Farms received the world's first regulatory approval for cultivated beef from Israel's Ministry of Health, covering its Petit Steak and Aleph Cuts products.[2][18][19] Despite the approval, Toubia chose to delay commercial launch to focus on cost reduction and scalability, describing the decision as a strategic reset.[20] The company reported a 97% reduction in production costs over a two-year R&D program completed by early 2025.[21] In June 2024, Aleph Farms laid off approximately 30% of its workforce amid broader financial pressures in the cultivated meat sector.[22]

In March 2025, the company raised a $29 million Series C round, comprising a $22 million SAFE conversion and $7 million from existing investors, to fund commercialization of a lower-cost whole-cut cultivated steak product.[23] Aleph Farms has pursued an Asia-Pacific-first commercial strategy, partnering with BBGI and Fermbox Bio to build a production facility in Thailand with a planned capacity of up to 1,000 tonnes per year.[24][25] The company has also acquired a 65,000-square-foot production facility in Rehovot, Israel, from VBL Therapeutics.[23] Total funding raised as of 2025 stands at approximately $148 million.[6]

Blue Tree Technologies (2017–present)

Concurrently with Aleph Farms, Toubia co-founded Blue Tree Technologies in 2017 and serves as chairman. The company focuses on sustainable nutrition and ingredient innovation.[1][8] Limited public information is available regarding the company's specific products or scale.

Yeap (2018–present)

Toubia co-founded Yeap in 2018, another venture in the sustainable nutrition and ingredient space.[1][8] Like Blue Tree Technologies, Yeap operates concurrently with Aleph Farms. Detailed public information on the company's product offering and current status is limited.

Israel Association for Advanced Technologies (IATI)

Toubia serves as a board member of the Israel Association for Advanced Technologies (IATI), an industry body representing Israel's technology sector.[1] Dates of appointment are not publicly documented.

ProVeg Incubator

Toubia serves as a mentor at the ProVeg Incubator, supporting early-stage alternative protein startups.[1]

Public statements

We decided not to launch last year, when the regulatory approval came through. We want to complete relatively extensive work we're doing on cost reduction, scalability, and production improvement. That's exactly what we didn't want to do. We didn't want to launch a product that will still be very expensive and not yet ripe for larger scale production.

On delaying commercial launch despite regulatory approval — FoodNavigator, 2025[6]

We decided two years ago to focus on Asia and the wider APEC region due to food security concerns. Many countries there rely on imported beef, and the acceptance of cultivated meat is as high as 70–90% in some places.

On the strategic pivot to Asia-Pacific markets — Future of Foods Podcast, 2025[21]

Investors are back to fundamentals. They want clear paths to profitability. That has pushed us to focus on launching a product that is both great and profitable.

On the post-hype investment environment — Green Queen, 2025[20]

Personal life

Toubia is a French national who relocated to Israel, where he has built his career across the medical device and food technology sectors. He is based in Kfar Saba, Israel.[1] His interest in food systems traces back approximately 25 years to his food engineering studies in France, and he has described his career as spanning "many careers" — from food and international development, to biotech and medical devices, to deep food technology — unified by a focus on systemic issues in food and health.[18] Toubia delivered a TEDx talk at TEDxIDCHerzliya in December 2020 titled "Cultivated Meat: Second Domestication," framing cellular agriculture as a civilizational shift comparable to humanity's first domestication of livestock.[27]

Media appearances

References

  1. Didier Toubia - World Economic Forum — World Economic Forum
  2. Aleph Farms' cultivated beef process receives blessing from Israeli government — TechCrunch, January 2024
  3. Aleph Farms Funding, Investors & Competitors — Multiples.vc
  4. Cleveland-funded Israeli biomedical company raises $10M in IPO — MedCity News, February 2011
  5. SeaSpine acquisition of NLT Spine could be worth $53m — MassDevice, August 2016
  6. Aleph Farms' Didier Toubia on GLP-1s and protein trends: a new cultivated meat strategy — FoodNavigator, September 2025
  7. Green Queen in Conversation: Cultivated Meat Pioneers – Didier Toubia of Aleph Farms — Green Queen
  8. Didier Toubia - TWIN Global — TWIN Global
  9. Didier Toubia - Co-Founder and CEO at Aleph Farms — The Org
  10. NLT Spine - About — NLT Spine
  11. Icecure Medical Ltd: Governance, Directors and Executives — MarketScreener
  12. Israeli Firm That Freezes Cancer Tumors Signs Distribution Deal In Japan, Singapore — NoCamels, September 2019
  13. SeaSpine Signs Definitive Agreement to Acquire Expandable Interbody Platform Technologies — SEC / SeaSpine Holdings, August 2016
  14. US co SeaSpine buys Israel's NLT Spine — Globes (Israel), August 2016
  15. Cultured Meat Startup Aleph Farms Raises $12m Series A from VisVires New Protein and Cargill — AgFunder News, May 2019
  16. Aleph Farms completes $105M Series B funding round — New Hope Network, July 2021
  17. Aleph Farms closes $105M funding round to bring cell-based meat to market in 2022 — Food Dive, July 2021
  18. Aleph Farms receives green light from Israel for cultured beef — Food Dive, January 2024
  19. Israel gives world's first regulatory approval to cultivated beef — Jewish News Syndicate, January 2024
  20. Aleph Farms CEO on Cultivated Meat Launch & Regulatory Plans for UAE & EU — Green Queen
  21. Future of Foods Podcast: Didier Toubia on Aleph Farms' Strategy for Cultivated Meat — Israel Trade / Future of Foods, February 2025
  22. Aleph Farms raised $140 million—but now it's struggling to survive — Calcalist Tech (CTech)
  23. Exclusive: Aleph Farms lands $29m to commercialize lower-cost whole-cut cultivated steak — AgFunder News, March 2025
  24. Aleph Farms partners with BBGI, Fermbox Bio in Thailand — AgFunder News
  25. Ep. 137 - Is the Future of Cultivated Meat in Thailand? Aleph Farms is Betting on It — Business for Good Podcast
  26. Aleph Farms Increases Production Capabilities with VBL Therapeutics Facility Acquisition and ESCO Aster Partnership — BioSpace
  27. Didier Toubia: Cultivated Meat: Second Domestication — TED
  28. High-stakes innovation: An interview with a cultivated-meat pioneer — McKinsey & Company
  29. My company makes cultivated meat. I have one big regret — Fast Company, March 2024

Is this your record?

Claim it to review for accuracy, or enrich it through a personal interview.

Claim your record
founderrecord.com/didier-toubia
FR–2026–0082·Updated October 14, 2026